Anagenics Limited reported earnings results for the full year ended June 30, 2023. For the full year, the company reported sales was AUD 9.11 million compared to AUD 6.95 million a year ago. Net loss was AUD 2.67 million compared to AUD 3.65 million a year ago.

Basic loss per share from continuing operations was AUD 0.0065 compared to AUD 0.0078 a year ago. Diluted loss per share from continuing operations was AUD 0.0065 compared to AUD 0.0078 a year ago. Basic loss per share was AUD 0.01 compared to AUD 0.0174 a year ago.

Diluted loss per share was AUD 0.01 compared to AUD 0.0174 a year ago.